EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND RENAL IMPAIRMENT: A SUBGROUP ANALYSIS OF ATOS STUDY

被引：0
|
作者：
Tirosh, A. [1 ]
Khan, N. [2 ]
Vargas-Uricoechea, H. [3 ]
Mabunay, M. A. N. [4 ]
Coudert, M. [5 ]
Pilorget, V. [6 ]
Galstyan, G. [7 ]
机构：
[1] Tel Aviv Univ, Div Endocrinol Diabet & Metab, Chaim Sheba Med Ctr, Tel Hashomer, Israel
[2] Imperial Coll London, Ctr Diabet, Al Ain, U Arab Emirates
[3] Univ Cauca, Dept Internal Med, Popayan Cauca, Colombia
[4] Sanofi, Gen Med, Singapore, Singapore
[5] Sanofi, Biostat & Programming, Paris, France
[6] Sanofi, Diabet & Cardiovasc Dev R&D, Paris, France
[7] Minist Russian Federat, Endocrinol Res Ctr Hlth Care, Diabet Foot Dept, Moscow, Russia
来源：
DIABETES TECHNOLOGY & THERAPEUTICS | 2022年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
EP049 / #2
引用
收藏
页码：A100 / A101
页数：2
相关论文
共 50 条
  • [1] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): A SUB ANALYSIS OF ATOS STUDY
    Khan, N.
    Al Shaikh, A. R.
    Hassoun, A.
    Mabunay, M. A. N.
    Magdy, A.
    Salah, M.
    Al Abdella, N.
    Safarini, S.
    Al Dahi, W.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A102 - A103
  • [2] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Insulin-Naive People with Type 2 Diabetes (T2DM) and Renal Impairment (RI): A Subgroup Analysis of the ATOS Study
    Tirosh, Amir
    Khan, Niaz
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen N.
    Coudert, Mathieu
    Pilorget, Valerie
    Galstyan, Gagik R.
    DIABETES, 2021, 70
  • [3] Real-world effectiveness and safety of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes and renal impairment: a subgroup analysis of the ATOS study
    Tirosh, A.
    Khan, N.
    Vargas-Uricoechea, H.
    Mabunay, M. A. N.
    Coudert, M.
    Pilorget, V.
    Galstyan, G.
    DIABETOLOGIA, 2021, 64 (SUPPL 1) : 264 - 265
  • [4] EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN NAIVE PEOPLE WITH TYPE 2 DIABETES: ATOS STUDY SUBGROUP ANALYSIS BY BASELINE HBA1C
    Khan, N.
    Tirosh, A.
    Vargas-Uricoechea, H.
    Mabunay, M. A. N.
    Coudert, M.
    Pilorget, V.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A100 - A100
  • [5] REAL-WORLD EFFECTIVENESS AND SAFETY OF INSULIN GLARGINE 300 U/ML (GLA-300) IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES (T2DM): THE ATOS STUDY
    Galstyan, G.
    Tirosh, A.
    Vargas-Uricoechea, H.
    Mabunay, M.
    Quan, J.
    Pilorget, V.
    Cherkasov, D.
    Naqvi, M.
    Khan, N.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2021, 23 : A23 - A23
  • [6] Effectiveness and Safety of Insulin Glargine 300 U/mL (Gla-300) in Insulin-Naive People with Type 2 Diabetes (T2DM): ATOS Study Subgroup Analysis by Baseline (BL) HbA1c
    Khan, Niaz
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen N.
    Coudert, Mathieu
    Pilorget, Valerie
    Galstyan, Gagik R.
    DIABETES, 2021, 70
  • [7] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Insulin-Naive People with Type 2 Diabetes: the ATOS Study
    Galstyan, Gagik R.
    Tirosh, Amir
    Vargas-Uricoechea, Hernando
    Mabunay, Maria Aileen
    Coudert, Mathieu
    Naqvi, Mubarak
    Pilorget, Valerie
    Khan, Niaz
    DIABETES THERAPY, 2022, 13 (06) : 1187 - 1202
  • [8] Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL (gla-300) in Insulin-Naive Patients with Type 2 Diabetes (T2DM): Interim Analysis of the ATOS Study
    Galstyan, Gagik R.
    Bhansali, Anil
    Vargas-Uricoechea, Hernando
    Tirosh, Amir
    Sun, Guannan
    Naqvi, Mubarak
    Pilorget, Valerie
    Coudert, Mathieu
    Cherkasov, Dmitry
    Khan, Niaz
    DIABETES, 2020, 69
  • [9] TITRATION PATTERNS OF INSULIN GLARGINE 300 U/ML IN INSULIN-NAIVE PEOPLE WITH TYPE 2 DIABETES AND CLINICAL OUTCOMES: A SUBGROUP ANALYSIS OF ATOS STUDY
    Tirosh, A.
    Singh, A. K.
    Vargas-Uricoechea, H.
    Mabunay, M. A.
    Bigot, G.
    Naqvi, M.
    Galstyan, G.
    DIABETES TECHNOLOGY & THERAPEUTICS, 2023, 25 : A132 - A133
  • [10] Titration patterns of insulin glargine 300 U/mL in insulin-naive people with type 2 diabetes and clinical outcomes: a subgroup analysis of ATOS study
    Tirosh, A.
    Singh, A.
    Vargas-Uricoechea, H.
    Mabunay, M. A.
    Bigot, G.
    Naqvi, M.
    Galstyan, G.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S355 - S355
12345